Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|June 4, 2026
A phylogeny-guided framework for decoding mechanisms of human endogenous retrovirus regulation in health and diseaseAndrew Patterson, Bryant Duong, Leena Yoon, et al.
Molecular Cell|December 15, 2019
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in MelanomaMarie R Webster, Mitchell E Fane, Gretchen M Alicea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate CancerRana R McKay, Shayan S Nazari, Andrew Elliott, et al.
Nature Communications|January 26, 2020
African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxinKumar Sachin Singh, Julia I-Ju Leu, Thibaut Barnoud, et al.
Nature Communications|March 21, 2020
Author Correction: African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxinKumar Sachin Singh, Julia I-Ju Leu, Thibaut Barnoud, et al.
Molecular Cancer Research : MCR|January 11, 2013
A modified HSP70 inhibitor shows broad activity as an anticancer agentGregor M Balaburski, Julia I-Ju Leu, Neil Beeharry, et al.
Oncotarget|November 27, 2020
Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolismAbram Calderon, Samantha S Soldan, Alessandra De Leo, et al.
Oncogene|April 27, 2018
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanomaPatricia Reyes-Uribe, Maria Paz Adrianzen-Ruesta, Zhong Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2023
Common activities and predictive gene signature identified for genetic hypomorphs of TP53Jessica C Leung, Julia I-Ju Leu, Alexandra Indeglia, et al.
Cancer Research Communications|July 13, 2023
The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint InhibitionDavid C Stieg, Joshua L D Parris, Tyler Hong Loong Yang, et al.
Pageof 12